{
    "code": "01033221",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01033221",
    "time": "2019-09-13 03:10:16",
    "許可證字號": "衛署藥製字第033221號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/12\/31",
    "發證日期": "79\/11\/23",
    "許可證種類": "製　劑",
    "舊證字號": "01023567",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103322102",
    "中文品名": "普樂舒膠囊２５０公絲（那普洛仙）",
    "英文品名": "PLOSON CAPSULES 250MG (NAPROXEN) &quot;C.S.P.&quot;",
    "適應症": "急慢性風濕關節炎、關節局部腫脹、強直性脊椎關節炎、脊椎炎、椎關節炎、關節周圍炎、上腕肩甲骨炎及骨骼肌不適之粘液囊炎、腱鞘炎等之消炎、鎮痛、解熱",
    "劑型": "130膠囊劑",
    "包裝": "盒裝 瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "NAPROXEN",
    "主製造廠": {
        "申請商名稱": "1413217200  嘉信藥品股份有限公司",
        "申請商地址": "嘉義市西區劉厝里劉富街60號",
        "主製造廠": "",
        "製造廠名稱": "0922116300  政德製藥股份有限公司"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808402000",
            "成分名稱": "NAPROXEN",
            "含量描述": "250",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010332210001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01033221&Seq=001&Type=9"
        }
    ]
}